Flerovium
Flerovium is a chemical element with the symbol Fl and atomic number 114. It is a superheavy element in the periodic table, belonging to the p-block and is a member of the 7th period and group 14 elements, also known as the carbon group. Flerovium is a synthetic element, meaning it is not found in nature but has to be created in a laboratory through the fusion of lighter atoms. Its most stable known isotope, flerovium-289, has a half-life of about 2.6 seconds, although this may vary slightly for other isotopes.
Discovery[edit]
Flerovium was first synthesized in December 1998 at the Joint Institute for Nuclear Research (JINR) in Dubna, Russia, by a team of Russian scientists led by Yuri Oganessian. The team bombarded atoms of plutonium-244 with ions of calcium-48, leading to the creation of flerovium-289 after emitting a couple of neutrons. The discovery was a significant milestone in the field of nuclear physics and chemistry, contributing to the understanding of the properties of superheavy elements.
Properties[edit]
Due to its extremely short half-life, studying flerovium's properties is challenging. Theoretical predictions suggest that flerovium may exhibit some properties similar to its lighter homologs, such as lead and tin, but with significant differences due to relativistic effects. These effects are particularly pronounced in superheavy elements and can lead to unexpected chemical and physical properties. For instance, flerovium is predicted to be a relatively inert, noble metal, possibly even more so than lead, contradicting earlier expectations that it would behave similarly to tin.
Naming[edit]
The name "flerovium" honors the Flerov Laboratory of Nuclear Reactions of JINR, itself named after the Soviet physicist Georgy Flyorov, who is known for his discovery of spontaneous fission. The name was officially adopted by the International Union of Pure and Applied Chemistry (IUPAC) in 2012, following the tradition of naming elements after their discoverers or places of discovery.
Applications[edit]
As of now, flerovium has no practical applications outside of scientific research due to its short half-life and the difficulty in producing it in significant quantities. The primary interest in flerovium and other superheavy elements lies in the insights they provide into the limits of the periodic table, the stability of nuclei, and the behavior of matter under extreme conditions.
See Also[edit]
References[edit]
This chemical element related article is a stub. You can help WikiMD by expanding it.
-
Flerovium
-
Nuclear shell model diagram
-
Proton shell model diagram
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian